sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Disclosure on Spire Healthcare Holdings
The Vanguard Group, Inc. has released a Form 8.3 disclosure concerning its position in Spire Healthcare Group plc. This document is a requirement under Rule 8.3 of the Takeover Code for entities with interests in relevant securities exceeding 1%.
As of June 19, 2026, Vanguard held 14,279,229 ordinary shares of Spire, representing 3.55% of the company's securities. Recent activities include the purchase of 6,837 shares and the sale of 192,037 shares, both at a rate of 2.16 GBP per unit. No cash or stock-settled derivative transactions or new agreements have been reported outside these dealings.
No indemnity or option arrangements or agreements on voting rights have been disclosed. Additionally, there are no supplemental forms attached to this announcement. This clear disclosure maintains transparency as required by the regulatory framework.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.